Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Salim Ivomas Pratama Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan Salim Ivomas Pratama Tbk. diperdagangkan di Rp615 (kapitalisasi pasar 9,61 T, volume 24 jam 18,49 jt). Perbedaan utamanya: Salim Ivomas Pratama Tbk. jauh lebih besar — sekitar 57,9× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Salim Ivomas Pratama Tbk. lebih aktif diperdagangkan (18,49 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | SIMP | |
|---|---|---|
Kapitalisasi Pasar | 166,01 M | 9,61 T |
Volume | 324 rb | 18,49 jt |
Lot | 3,24 rb | 184,87 rb |
Perputaran | 77,68 jt | 11,38 M |
Harga Rata-rata | 239,75 | 615,52 |
Nilai Transaksi | 77,68 jt | 11,38 M |
Harga Ekuilibrium Indikatif | 240 | 615 |
Volume Ekuilibrium Indikatif | 1 | 2,65 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Salim Ivomas Pratama Tbk (the company) was established under its original name of PT Ivomas Pratama base on notarial deed No.65 of Mrs Maria Kidarsa, S.H, dated on 12 Aug, 1992. The Company’s articles of association has been amended several times, most recently by notarial deed No. 46 of Benny Kristianto, S.H., dated Dec 14, 2010, concerning among others, the change in the Company’s name, par value and public offering.
Selengkapnya di halaman SIMP →